期刊档案 · CARDIAC & CARDIOVASCULAR SYSTEMS
European Heart Journal-Quality of Care and Clinical Outcomes
ISSN 2058-5225 · eISSN 2058-1742 · OXFORD UNIV PRESS · ENGLAND
European Heart Journal-Quality of Care and Clinical Outcomes 中科院 医学 2区(2025 年升级版),影响因子 5.47,混合开放获取,APC 约 4,591 美元,近 24 个月 73 篇文章投稿到接收中位 88 天,2025 年发文 174 篇,SCIE、Scopus 收录。
研究范围
研究范围与定位
European Heart Journal-Quality of Care and Clinical Outcomes 由 OXFORD UNIV PRESS 出版,属中科院医学大类(2025 升级版2区)。按 OpenAlex 近年发文统计,该刊主要发表 Acute Myocardial Infarction Research、Atrial Fibrillation Management and Outcomes、Heart Failure Treatment and Management 等主题的论文,这 3 个主题约占 29%,主导子领域为 Cardiology and Cardiovascular Medicine。(根据 OpenAlex 主题统计与中科院分区数据生成)
The European Heart Journal – Quality of Care and Clinical Outcomes (EHJ-QCCO) is an official, peer-reviewed journal of the European Society of Cardiology with a close alliance to the European Heart Health Institute (EHHI) publishing cardiovascular outcomes research. Mission Statement The objective of the EHJ-QCCO is to advance innovative research in cardiovascular health and disease outcomes, with implications for the organisation of the cardiovascular care. A central aim is to inform and shape effective policy strategies—such as national screening programmes, tobacco control policies, salt reduction initiatives, healthy environmental promotion, and equitable access to preventive care—while driving the practical application of evidence-based interventions through implementation science. We actively seek research that evaluates health policies, economic implications, and cost-effectiveness, supporting decision-makers in translating research into sustainable public health and clinical practices. Our audience includes researchers, clinicians, data scientists, and policymakers dedicated to improving cardiovascular outcomes through robust policy and implementation initiatives. The journal prioritises the publications of scientific contributions in: Epidemiology and population health, focusing on cardiometabolic risk factors in community settings The impact of healthcare delivery on cardiovascular outcomes within health systems and communities Cardiovascular disease prevention, including clinical trials, community interventions, and implementation science Issues published per year: 8 Articles available: online only from January 2025 Access: subscription with optional open access Why Publish with EHJ-QCCO? Discover the top 5 reasons to submit your manuscript to the Journal. Journal metrics Citation metrics Clarivate 2025 Impact Factor 5.6 2025 5 Year Impact Factor 5.2 Cardiac & Cardiovascular Systems (Rank by Impact Factor) 44/237 2025 Journal Citation Indicator (JCI) 1.26 Cardiac & Cardiovascular Systems (Rank by Journal Citation Indicator) 46/237 2025 Cited Half-Life 3.7 years 2025 Immediacy Index 2.2 2025 Eigenfactor Score 0.00546 2025 Article Influence Score 1.79 Scopus 2025 CiteScore 10.0 Health Policy (Rank by CiteScore) 12/330 Cardiology And Cardiovascular Medicine (Rank by CiteScore) 36/409 2025 Source Normalized Impact per Paper (SNIP) 1.672 About metrics Disclaimer Unless otherwise expressly indicated, statements of fact and opinion in the articles in E
摘自期刊官网 Aims & Scope
研究方向(LetPub):CARDIAC & CARDIOVASCULAR SYSTEMS
主编 Massimo Piepoli出版商官网
编委会国家分布:中国大陆 2 位(约 4%);主要国家 意大利 14、英国 12、美国 7、加拿大 3、中国 2(共 57 位编委标注了国家) 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计,占比为近似值
- Acute Myocardial Infarction ResearchMedicine12.2%
- Atrial Fibrillation Management and OutcomesMedicine8.7%
- Heart Failure Treatment and ManagementMedicine8.1%
- Cardiac Imaging and DiagnosticsMedicine7.6%
- Cardiac Valve Diseases and TreatmentsMedicine6.5%
- Cardiovascular Function and Risk FactorsMedicine6%
- Cardiac Health and Mental HealthMedicine6%
- Coronary Interventions and DiagnosticsMedicine5.9%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表( 2025年3月升级版)医学 2 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 2 区 |
| 小类 | 心脏和心血管系统CARDIAC & CARDIOVASCULAR SYSTEMS | 2 区 |
Top 期刊:否综述期刊:否
《新锐期刊分区表》( 2026年3月发布)医学 2 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 2 区 |
| 小类 | 心脏和心血管系统CARDIAC & CARDIOVASCULAR SYSTEMS | 2 区 |
Top 期刊:否综述期刊:未标注
期刊分区表( 2023年12月旧的升级版)医学 2 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 2 区 |
| 小类 | 心脏和心血管系统CARDIAC & CARDIOVASCULAR SYSTEMS | 3 区 |
Top 期刊:否综述期刊:否
数据库收录
SCIEScopusLetPub
国际期刊预警名单:各版本均未列入LetPub
不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子
- 5.47LetPub ·
- 影响因子(出版商公布) 2025
- 44出版商官网 ·
- 五年影响因子(出版商公布) 2025
- 5.2出版商官网 ·
- CiteScore 2026-06
- 10LetPub ·
- CiteScore(出版商公布) 2025
- 10出版商官网 ·
- SJR 2026-06
- 2.23LetPub ·
- SNIP 2026-06
- 1.67LetPub ·
- h-index
- 55OpenAlex ·
- i10-index
- 411OpenAlex ·
- 两年平均被引
- 3.51OpenAlex ·
- 自引率
- 12.5%LetPub ·
- Gold OA 文章占比
- 38.98%LetPub ·
发文规模
- 年文章数
- 103LetPub ·
逐年发文量 OpenAlex 统计 · 累计 1,073 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 151 | 51 | 103 |
| 2025 | 174 | 66 | 551 |
| 2024 | 107 | 72 | 862 |
| 2023 | 74 | 65 | 1,129 |
| 2022 | 91 | 55 | 1,417 |
| 2021 | 102 | 63 | 2,050 |
不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 PubMed 登记的稿件日期 · 至
88 天投稿到接收中位数 · P25–P75 57 天 – 120 天
- 接收到上线
- 中位数 10 天(33 篇)
- 投稿到上线
- 中位数 82 天
- 样本
- 73 篇有投稿与接收日期的文章(窗口内共 419 篇),最近一篇接收于
只统计最终被录用并发表的文章,不含被拒稿件的处理时间,因此通常长于出版商公布的"首次决定时间"。
其他来源
- 评审方式
- 单盲同行评审出版商官网
社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
订阅期刊,作者可付费选择开放获取发表。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| OpenAlex | EUR 4,062 | — | — | |
| 出版商官网 | 有,金额未公布 | — | — |
混合期刊的文章处理费仅在作者选择开放获取发表时收取;按订阅方式发表通常不收费。
其他费用与减免(作者指南)
- 彩图费
- 无彩图费
- 版面费
- 无版面费
- 投稿费
- 无投稿费
费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。
投稿要求
文章类型与投稿政策(官网)
投稿准备要点6 项,摘自作者指南
- 摘要
- ≤ 250 词
- 关键词
- ≤ 6 个
- 正文篇幅
- ≤ 5,000 词
- 参考文献格式
- Vancouver 格式
- Highlights(研究亮点)
- 必须提供
- 图文摘要
- 可选
接收的文章类型10 种,含篇幅限制
- cohort profileCohort Profile—Maximum Word Count: 2000未说明篇幅
- correspondenceOriginal Article—Maximum Word Count: 5000 Review—Maximum Word Count: 5000 Cohort Profile—Maximum Word Count: 2000 Rapid Communication—Maximum Word Count: 1000 C…参考文献 ≤ 6
- editorialOriginal Article—Maximum Word Count: 5000 Review—Maximum Word Count: 5000 Cohort Profile—Maximum Word Count: 2000 Rapid Communication—Maximum Word Count: 1000 C…参考文献 ≤ 6
- esc official outputESC Official Output未说明篇幅
- highlights and meeting reportsHighlights and Meeting Reports—Maximum Word Count: 1000未说明篇幅
- meta-analysisThe article types accepted by the Journal are listed below. All word counts are exclusive of references, figure legends, tables, the title page, and the abstrac…未说明篇幅
- original articleOriginal Article—Maximum Word Count: 5000 Review—Maximum Word Count: 5000 Cohort Profile—Maximum Word Count: 2000 Rapid Communication—Maximum Word Count: 1000 C…图表 ≤ 6 · 参考文献 ≤ 6
- rapid communicationOriginal Article—Maximum Word Count: 5000 Review—Maximum Word Count: 5000 Cohort Profile—Maximum Word Count: 2000 Rapid Communication—Maximum Word Count: 1000 C…参考文献 ≤ 6
- reviewOriginal Article—Maximum Word Count: 5000 Review—Maximum Word Count: 5000 Cohort Profile—Maximum Word Count: 2000 Rapid Communication—Maximum Word Count: 1000 C…正文 ≤ 5,000 词 · 图表 ≤ 6 · 参考文献 ≤ 50
- systematic reviewThe article types accepted by the Journal are listed below. All word counts are exclusive of references, figure legends, tables, the title page, and the abstrac…未说明篇幅
官网政策摘录作者资格、利益冲突、数据可用性、出版伦理、开放获取、同行评审、查重、预印本、自存档
- 作者资格 Authorship
署名政策要求所有列名作者均须符合国际医学期刊编辑委员会(ICMJE)规定的全部作者资格条件,包括对工作的构思设计或数据获取、分析、解读作出实质性贡献,并参与撰写或批判性审阅。 模型中文摘要
All individuals listed as authors should qualify for authorship and should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Each author included in the manuscript must meet ALL of the following conditions, as specified in the guidelines of the International Committee of Medical Journal Editors (ICMJE). To qualify as an author, the in…
原文 ↗出版商官网 ·- 利益冲突 Conflict of Interest
利益冲突政策要求所有作者申报任何利益冲突,投稿作者有责任从合著者处了解并在投稿时申报,凡若不申报且在发表后曝光可能令作者尴尬的潜在利益冲突均应申报。 模型中文摘要
All authors must declare any conflicts of interest. It is the responsibility of the submitting author to ascertain any conflicts of interest from co-authors and declare these at the point of submission. Any potential conflict of interest that might constitute an embarrassment to any of the authors if it were not to be declared and were to emerge after publication should be declared. A detailed def…
原文 ↗出版商官网 ·- 数据可用性
数据可用性政策指出,在伦理允许的情况下,期刊强烈鼓励作者将论文结论所依据的所有数据和软件代码提供给读者。 模型中文摘要
Where ethically feasible, EHJ-QCCO strongly encourages authors to make all data and software code on which the conclusions of the paper rely available to readers.
原文 ↗出版商官网 ·- 出版伦理 Publication Ethics and Malpractice Statement
伦理政策说明期刊与牛津大学出版社是出版伦理委员会(COPE)成员并遵循COPE核心实践指南,同时遵循ICMJE建议,并承诺调查涉及编辑、作者和审稿人的不当行为指控。 模型中文摘要
EHJ-QCCO and Oxford University Press are members of the Committee on Publication Ethics (COPE), and follows the guidance provided in the COPE Core Practices. The Journal also subscribes to the International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly work in Medical Journals. It is expected that all parties involved …
原文 ↗出版商官网 ·- 开放获取 Open Access
开放获取政策说明作者可选择标准许可或开放获取许可发表,部分资助机构要求开放获取发表,作者应与资助方或机构确认要求,标准许可发表不收费,开放获取发表则需支付开放获取费用。 模型中文摘要
EHJ-QCCO offers authors the option of publishing under a standard licence or an open access licence. Some funders require open access publication as a condition of funding. Authors should clarify any requirements with their funder or institution. In signing a standard licence to publish the corresponding author (on behalf of all authors) grants an exclusive licence to the European Society of Cardi…
原文 ↗出版商官网 ·- 同行评审 Peer Review
同行评审政策说明所有投稿先由编辑及其同事初审,不符合投稿要求、优先级不高或与期刊不相关的稿件可能不经同行评审即退回作者,通过初审的稿件将由至少两名审稿人进行单盲同行评审。 模型中文摘要
All manuscripts submitted to the Journal are initially reviewed by the Editors and their associates. At this stage manuscripts may be returned to the authors without peer review if it is felt that they do not meet submission requirements, are not of high enough priority, or not relevant to the Journal. This fast rejection process means that authors are given a quick decision and do not need to wai…
原文 ↗出版商官网 ·- 查重 Plagiarism and Redundant Publication
剽窃政策引用COPE的定义,将剽窃界定为某人将他人的工作(数据、文字或理论)当作自己的成果呈现且未作恰当致谢,将冗余发表界定为已发表的作品或其大部分内容未经充分说明来源或理由而再次发表。 模型中文摘要
COPE defines plagiarism as ‘when somebody presents the work of others (data, words or theories) as if they were his/her own and without proper acknowledgement’. COPE defines redundant publication as ‘when a published work (or substantial sections from a published work) is/are published more than once (in the same or another language) without adequate acknowledgment of the source/cross-referencing/…
原文 ↗出版商官网 ·- 预印本 Preprints and Self-Archiving
预印本政策说明作者保留通过多种渠道提供作者原始版本(预印本)的权利且不影响向本刊投稿,投稿时应说明是否有预印本,论文被接受后作者须更新预印本状态并添加已发表论文的DOI。 模型中文摘要
Authors retain the right to make an Author’s Original Version (preprint) available through various channels and this does not prevent submission to the Journal. At initial submission, authors should indicate if any preprint is available in a server or repository. If accepted, the authors are required to update the status of any preprint, including adding the published paper’s DOI. For full details…
原文 ↗出版商官网 ·- 自存档 Preprints and Self-Archiving
自存档政策说明作者保留通过多种渠道提供作者原始版本(预印本)的权利且不影响向本刊投稿,投稿时应说明是否有预印本,论文被接受后作者须更新预印本状态并添加已发表论文的DOI。 模型中文摘要
Authors retain the right to make an Author’s Original Version (preprint) available through various channels and this does not prevent submission to the Journal. At initial submission, authors should indicate if any preprint is available in a server or repository. If accepted, the authors are required to update the status of any preprint, including adding the published paper’s DOI. For full details…
原文 ↗出版商官网 ·
摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。
基本信息
出版信息与官方入口
- 出版商
- OXFORD UNIV PRESS
- 出版国家或地区
- ENGLAND
- 出版语言
- English
- ISSN
- 2058-5225
- 电子版 ISSN
- 2058-1742
- 官网最新一期
- Volume 12, Issue 6(2026 年 9 月)
- 官方链接
- 期刊主页 ↗OpenAlex
- 投稿系统 ↗出版商官网
- 专刊 / 特刊征稿 ↗出版商官网
常见问题
关于 European Heart Journal-Quality of Care and Clinical Outcomes 的常见问题
European Heart Journal-Quality of Care and Clinical Outcomes 是中科院几区期刊?
2025 年升级版分区表中,European Heart Journal-Quality of Care and Clinical Outcomes 为医学 2区,小类 心脏和心血管系统 2 区。2026 年新锐版分区表中为医学 2区。不同版本与大小类分区不能混用。
European Heart Journal-Quality of Care and Clinical Outcomes 的影响因子是多少?
LetPub 汇总的最新公布影响因子为 5.47,CiteScore 为 10,h-index 为 55。
European Heart Journal-Quality of Care and Clinical Outcomes 的审稿周期多长?
按 2024年10月至2026年10月(近 24 个月)73 篇已发表文章登记的日期,投稿到接收的中位数为 88 天(四分位 57–120 天)。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。
European Heart Journal-Quality of Care and Clinical Outcomes 的投稿格式要求是什么?
据期刊作者指南:摘要:≤ 250 词;关键词:≤ 6 个;正文篇幅:≤ 5,000 词;参考文献格式:Vancouver 格式;Highlights:必须提供;图文摘要:可选。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。
European Heart Journal-Quality of Care and Clinical Outcomes 的编委会里有中国学者吗?
期刊官网编委会页面上标注了国家的 57 位编委中,中国大陆 2 位(约 4%);人数最多的国家是 意大利(14 位)、英国(12 位)、美国(7 位)。统计按编委会页面列出的机构国家计,仅供参考。
European Heart Journal-Quality of Care and Clinical Outcomes 被哪些数据库收录?
据 LetPub 与 DOAJ 记录,European Heart Journal-Quality of Care and Clinical Outcomes 被 SCIE、Scopus 收录。
European Heart Journal-Quality of Care and Clinical Outcomes 是开放获取期刊吗?版面费多少?
European Heart Journal-Quality of Care and Clinical Outcomes 为混合开放获取。选择开放获取发表时APC 约 4,591 美元。
来源与更新
本页事实来自 LetPub、OpenAlex、出版商官网;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-26 归档)。最近更新:。